A lysosomal storage disorder in mice characterized by a dual deficiency of sphingomyelinase and glucocerebrosidase
- PMID: 6257302
- DOI: 10.1016/0005-2760(80)90116-2
A lysosomal storage disorder in mice characterized by a dual deficiency of sphingomyelinase and glucocerebrosidase
Abstract
Lipid and lysosomal enzyme levels in the tissues of a strain of mice afflicted with an autosomal rescessive neuroviscereal storage disorder were examined. Sphingomyelinase and glucocerebrosidase activities were consistently diminished in a wide variety of tissues obtained from the affected mice. The activities of these enzymes were clearly attenuated in new-born mice, which at this age, were otherwise indistinguishable from littermates and age-matched controls. The deficiency of sphingomyelinase was more pronounced than glucocerebrosidase. There was progressive accumulation of sphingomyelin, glucocerebroside, lactosylceramide and unesterified cholesterol in the tissues of these mice in the postnatal period. Gangliosides GM2 and GM3 accumulated in the brain of the animals, and GM3 and asialo-GM2 were stored in the liver. Furthermore, there was a large increase in the quantity of hepatic bis(monoacylglycero)phosphate. The accumulation of lipids was parallelled by a progressive elevation in the activity of several lysosomal hydrolases in various tissues. Heterozygous mice were biochemically indistinguishable from normal controls. The phenotypic manifestations in these metabolically mutated animals are compared with those in Niemann-Pick disease and Gaucher's disease in humans.
Similar articles
-
A genetic storage disorder in BALB/C mice with a metabolic block in esterification of exogenous cholesterol.J Biol Chem. 1984 May 10;259(9):5784-91. J Biol Chem. 1984. PMID: 6325448
-
A lysosomal storage disorder in mice characterized by the accumulation of several sphingolipids.Birth Defects Orig Artic Ser. 1980;16(1):225-30. Birth Defects Orig Artic Ser. 1980. PMID: 7448355
-
Time course of hepatic lipids accumulation in a strain of mice with an inherited deficiency of sphingomyelinase.J Hered. 1983 Nov-Dec;74(6):465-8. doi: 10.1093/oxfordjournals.jhered.a109840. J Hered. 1983. PMID: 6315811
-
[Advances in molecular genetics of the Niemann-Pick group of diseases].Nihon Rinsho. 1993 Sep;51(9):2293-9. Nihon Rinsho. 1993. PMID: 8411705 Review. Japanese.
-
Basic findings and current developments in sphingolipidoses.Hum Genet. 1979 Mar 12;47(2):113-34. doi: 10.1007/BF00273194. Hum Genet. 1979. PMID: 108196 Review.
Cited by
-
Plasmid DNA gene therapy of the Niemann-Pick C1 mouse with transferrin receptor-targeted Trojan horse liposomes.Sci Rep. 2020 Aug 7;10(1):13334. doi: 10.1038/s41598-020-70290-w. Sci Rep. 2020. PMID: 32770132 Free PMC article.
-
Impaired Retromer Function in Niemann-Pick Type C Disease Is Dependent on Intracellular Cholesterol Accumulation.Int J Mol Sci. 2021 Dec 9;22(24):13256. doi: 10.3390/ijms222413256. Int J Mol Sci. 2021. PMID: 34948052 Free PMC article.
-
Evidence for the deficiency of beta-glucosidase-activating factor in fibroblasts of patients with I-cell disease.Hum Genet. 1982;62(1):66-9. doi: 10.1007/BF00295605. Hum Genet. 1982. PMID: 6818133
-
Localization of Niemann-Pick C1 protein in astrocytes: implications for neuronal degeneration in Niemann- Pick type C disease.Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1657-62. doi: 10.1073/pnas.96.4.1657. Proc Natl Acad Sci U S A. 1999. PMID: 9990080 Free PMC article.
-
NPC1 enables cholesterol mobilization during long-term potentiation that can be restored in Niemann-Pick disease type C by CYP46A1 activation.EMBO Rep. 2019 Nov 5;20(11):e48143. doi: 10.15252/embr.201948143. Epub 2019 Sep 18. EMBO Rep. 2019. PMID: 31535451 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous